Abeona Therapeutics Inc.
ABEO
$5.83
-$0.02-0.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -118.55% | -41.95% | -120.17% | 82.95% | 1,369.52% |
| Total Depreciation and Amortization | 8.46% | 6.63% | 40.72% | 22.99% | 12.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 107.55% | 43.12% | 147.74% | -99.37% | -520.24% |
| Change in Net Operating Assets | -157.56% | 57.45% | 84.54% | -9,464.61% | 539.42% |
| Cash from Operations | 6.86% | -7.62% | -8.42% | -73.18% | -48.09% |
| Capital Expenditure | 83.49% | 33.26% | -90.26% | -523.76% | -308.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -89.82% | 5.06% | -45.04% | -977.69% | 465.54% |
| Cash from Investing | -89.94% | 17.80% | -49.39% | -947.95% | 453.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -34.45% | -- | -85.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 83.33% | -- | 100.00% | 100.00% | 57.14% |
| Cash from Financing | -131.78% | -132.83% | -31.99% | 1,826.76% | -85.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -103.49% | -129.93% | -162.70% | -331.29% | 775.02% |